BioSpace News Archive

Drug Development

Bioverativ Announces First Patient Dosed in Phase 3 Study of BIVV009 for Treatment of Cold Agglutinin Disease

Significant unmet need for a treatment for cold agglutinin disease, a chronic rare blood disease that can result in life-threatening events like stroke.

March 6, 2018
·
7 min read
Business

GlycoMimetics Reports Fourth Quarter and Year-End 2017 Results

The Phase 3 trial of rivipansel remains on track for completion during the second half of 2018.

March 6, 2018
·
7 min read
Deals

Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy

Advances strategy to become a leader in global cellular immunotherapy.

March 6, 2018
·
2 min read
BioMidwest

Aptinyx Presents NYX-2925 Preclinical Data in Chemotherapy-induced Neuropathic Pain at the American Pain Society Annual Scientific Meeting

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced their presentation at the American Pain Society’s Annual Scientific Meeting, March 4-6, 2018 in Anaheim, CA.

March 6, 2018
·
3 min read
Job Trends

ESO Launches Surveillance Form for Overdose

Specialty Patient Form to help standardize definitions and data collection, highlight responder safety.

March 6, 2018
·
3 min read
Job Trends

Masimo Announces Replica™

Replica allows clinicians to remotely monitor patients from aywhere in real time.

March 6, 2018
·
7 min read
Business

Wiley Reports Third Quarter 2018 Results

Year-to-date revenue up 4% to $1,318.9 million, or up 1% at constant currency

March 6, 2018
·
23 min read
OrthoXel Announces World’s First Patient Surgical Implantation of the Apex Tibial Nailing System

Harty successfully completed the world’s first clinical use of the Apex Tibial Nailing System in Cork University Hospital on Saturday 3rd March.

March 6, 2018
·
3 min read
Deals

SCYNEXIS Announces Pricing of $30.0 Million Public Offering of Common Stock and Warrants

SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the pricing of its underwritten public offering of common stock and warrants.

March 6, 2018
·
4 min read
Pharm Country

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care

The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

March 6, 2018
·
4 min read